AbCellera Biologics
ABCL
ABCL
116 hedge funds and large institutions have $1.98B invested in AbCellera Biologics in 2021 Q3 according to their latest regulatory filings, with 28 funds opening new positions, 48 increasing their positions, 25 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 114 → 116 (+2)
8% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 26
0% less capital invested
Capital invested by funds: $1.99B → $1.98B (-$8.58M)
Holders
116
Holding in Top 10
8
Calls
$65.4M
Puts
$30.4M
Top Buyers
| 1 | +$128M | |
| 2 | +$38.7M | |
| 3 | +$19.1M | |
| 4 |
Millennium Management
New York
|
+$15.7M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$13.2M |
Top Sellers
| 1 | -$40.9M | |
| 2 | -$29.4M | |
| 3 | -$9.9M | |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$9.29M |
| 5 |
Blackstone Inc
New York
|
-$7.7M |